Skip to main content
Clinical Trials/NCT00006427
NCT00006427CompletedPhase 4

Management of Chronic Pain in Rehabilitation Project II Management of Chronic Pain in Persons With Amputation

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2 sites in 1 country125 target enrollmentStarted: August 1, 1996Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
125
Locations
2

Study Overview

Brief Summary

This trial will test the effectiveness of amitriptyline in relieving chronic pain of adults that have had an amputation

Detailed Description

This double-masked placebo controlled trial will randomize patients (n=125) who are 6 months or more after amputation and have a 3 or more month history of pain to a daily dose of amitriptyline or a placebo for 6 weeks. Patients will receive a complete functional neurological examination by one of the study physicians or nurses masked to their treatment assignment. Study participants will also be interviewed by telephone to assess pain, pain interference with activities, physical and mental health, and number of health care visits for pain, at the beginning and end of the six-week trial and four months later.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Double

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Amputation six months ago or longer
  • Pain for 3 months or longer

Exclusion Criteria

  • History of cardiovascular disease, seizures, or glaucoma
  • Currently taking antidepressant medications
  • Currently hyperthyroid or taking thyroid medication
  • Currently pregnant

Investigators

Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Sponsor Class
Nih

Study Sites (2)

Loading locations...

Similar Trials